Asia-Pacific infection control market is projected to register a CAGR of 16.9% in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:
Asia-Pacific Infection Control Market, By Product (Sterilization Products, Cleaning and Disinfection Products, Personal Protective Barriers, Endoscope Reprocessing Products, Anti-Microbial Surfaces, Other Infection Control Products), Application (Surgical Instruments, Endoscopes, Ultrasound Probes, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors), End User (Hospitals, Clinics, Medical Device Companies, Pharmaceutical and Biotechnology Companies, Laboratories, Others), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific)- Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the Asia-Pacific infection control market are:

- Increasing geriatric population
- Strategic initiatives by the government

Market Players:

The key market players for Asia-Pacific infection control market are listed below:
- 3M
- STERIS plc
- Getinge AB
- MMM Group
- Cantel Medical
- MATACHANA GROUP
- Ecolab
- Cardinal Health
- Steelco S.p.A.
- Reckitt Benckiser Group plc
- Metrex Research, LLC., Stryker
- B. Braun Melsungen AG
- Covalon Technologies Ltd.
- SKYTRON, LLC
- Olympus Corporation of the Americas (A Subsidiary of Olympus Corporation)
- COLTENE Group
- Pal International
- MELAG Medizintechnik GmbH & Co. KG
- Cisa Production S.r.l. Unipersonale
- TERRAGENE SA
- The Clorox Company